Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study

Description

This study will involve LVAD patients who have already received a clinically-indicated BAT (BAROSTIM) device. After recovery from LVAD implant, we will investigate the effects of BAT in a double-blind cross-over study design.

Conditions

Congestive Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will involve LVAD patients who have already received a clinically-indicated BAT (BAROSTIM) device. After recovery from LVAD implant, we will investigate the effects of BAT in a double-blind cross-over study design.

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study (BAT-VAD Study)

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study

Condition
Congestive Heart Failure
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age \> 18 years
  • * LVAD patient \> 3 months post implant
  • * Existing BAT device
  • * Presence of cardiogenic shock, respiratory failure, hypotension or unstable heart failure
  • * Bradycardia (resting HR \<60 beats/minute)
  • * Presence of suspected pump thrombosis at the time of enrollment
  • * Presence of any significant ventricular arrhythmias at the time of enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Brian Houston,

Study Record Dates

2027-04-25